Sponsor Pipeline

Polaryx Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
1
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-31 NCT07740512 Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric… Phase 2 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04637282 Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3 Juvenile Neuronal Ceroid Lipofuscinosis Not Yet Recruiting
Phase 2
NCT07740512 Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric… Lysosomal Storage Disorders Not Yet Recruiting
Get alerts when Polaryx Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free